Actuate Therapeutics Inc
ACTU · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Operating Activities | – | – | – |
| Net Income | -$27,285 | -$24,745 | -$20,159 |
| Dep. & Amort. | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 |
| Stock-Based Comp. | $1,996 | $424 | $654 |
| Change in WC | $1,100 | $2,572 | $1,732 |
| Other Non-Cash | $2,347 | $123 | -$20 |
| Operating Cash Flow | -$21,843 | -$21,625 | -$17,794 |
| Investing Activities | – | – | – |
| PP&E Inv. | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 |
| Financing Activities | – | – | – |
| Debt Repay. | $5,500 | $0 | $0 |
| Stock Issued | $23,957 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 |
| Other Fin. Act. | -$1,931 | $0 | $0 |
| Financing Cash Flow | $27,526 | $4,135 | $19,256 |
| Forex Effect | $0 | $0 | $0 |
| Net Chg. in Cash | $5,683 | -$17,491 | $1,461 |
| Supplemental Information | – | – | – |
| Beg. Cash | $2,959 | $20,449 | $18,988 |
| End Cash | $8,642 | $2,959 | $20,449 |
| Free Cash Flow | -$21,843 | -$21,625 | -$17,794 |